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Abstract 
 
Aims and Objective: Correlation between serum cholesterol level and risk of breast cancer. 
Material and Methods: Fifty histologically diagnosed breast cancer patients were included in the study. Patients 
were grouped according to the size, histological type of the tumor and lymph node involvement. Patient’s total 
serum cholesterol levels were measured a week prior to the operation and on the 14th day postoperatively. Fifty age-
matched non-cancer females were treated as a control. 
Observations: The pre and postoperative mean total serum cholesterol (MTSC) was found to be 272.3 ± 43.4mg/dl 
and 210.54 ± 31.5mg/dl respectively. An MTSC level in fifty control cases was found to be 183.42 ± 34.4mg/dl. 
Patients with tumor size less than 5cms showed preoperative mean serum cholesterol levels of 261.6 ± 36.5mg/dl 
and a postoperative value of 201.9 ± 16.9mg/dl while those with tumor size more than 10cms showed a mean serum 
cholesterol level of 282.36 ± 64.8mg/dl preoperatively and 211.82 ± 53.15mg/dl postoperatively. Thirty patients 
with scirrhous type of carcinoma had a preoperative mean serum cholesterol level as 237.36mg/dL, and twelve 
patients with a colloid type of carcinoma showed a preoperative level of 294.9 ± 18.4mg/dL whereas eight patients 
with medullary type of carcinoma showed the highest preoperative level of 324.3 ± 19.8mg/dL, whereas the 
corresponding postoperative values were 202.9 ± 30.0mg, 216.8 ± 27.8mg and 229.4 ± 29.8mg respectively. 
Conclusions: The present study helps us to conclude that dietary habits affect the association of cholesterol in breast 
cancer and size, histology with tumor metastasis effects such relationship. 
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1. Introduction 
 
Breast cancer is a major cause of death in older 
females. Investigations like aspiration cytology, biopsy, 
mammography, sonography, computerized scanning 
and many biochemical parameters now help to diagnose 
the lesions in its infancy before the life of patients is 
endangered. 
For long, a number of workers have undertaken 
studies on metabolic chemistry in relation to Cancer. 
Chao et al.,1 concluded in their study that decrease in 
serum cholesterol level was related to the mortality of 
cancer patients. When the serum cholesterol levels fell 
to less than half their initial levels chances of mortality 
increased. Rose and Simpley2 observed the correlation 
between low serum cholesterol level and an increased 
risk of cancer. They also explored the possibility that 
rather than low serum cholesterol levels predisposing to 
cancer, existing cancer at the time of serum cholesterol 
measurement may cause the cholesterol levels to 
decrease. This "preclinical cancer effect" could yield 
the apparent correlation between lower serum 
cholesterol level and cancer mortality. Alexopoulos et 
al.,3 carried out a study on 103 cancer patients (60 men 
and 43 women, with a mean age group of 56 years) and 
100 age-matched non-cancer patients to infer that 
cancer patients showed significantly lower serum 
cholesterol level as compared to the non-cancer 
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patients, with the only exception of the breast cancer 
patients who revealed raised serum total cholesterol 
levels. 
 
2. Material and Methods 
 
Fifty cytologically and histologically diagnosed 
breast cancer patients (with a mean age group of 57.7 
years) attending surgery outpatient and inpatient of 
Jawaharlal Nehru Medical College, Aligarh were 
included in the study. Patients were grouped according 
to the size, histological type of the tumor and lymph 
node involvement. Patient’s total serum cholesterol 
levels were measured a week prior to the operation and 
on the 14th day postoperatively. Fifty age-matched non-
cancer females (with a mean age group of 56.5 years) 
were treated as a control. 
The criteria for selection of patients with reference 
to the control were age, weight, blood pressure, dietary 
habit and economic status, 32 patients were non-
vegetarian and 18 were vegetarian and none of the 
females were smoker or alcoholic. In the control group, 
also 32 were non-vegetarian and 18 were vegetarian. 
The fifty pre-treatment breast cancer patients were 
investigated by fine needle aspiration cytology (FNAC) 
and later confirmed by histopathology after operation. 
The diagnoses by both methods were 100% the same, 
although FNAC was repeated in 17 out of 50 patients 
because of scanty material or hemorrhagic smears.  
3ml venous blood was drawn after 12 hours 
fasting, taken in the sterilized plain vials, and allowed 
to clot, undisturbed at 37°C. Serum was separated by 
centrifugation at 4000rpm for 10 min. and stored at 
20°C till the cholesterol estimation was done. 
Hemolysed samples were discarded. Serum cholesterol 
estimation was done on semi autoanalyzer (Ranbaxy 
BTR - 820) on the principle of CHOD -PAP (Enzo kit - 
cholesterol).4 
 
3. Observations 
 
The pre and postoperative mean total serum 
cholesterol (MTSC) in fifty breast cancer patients with 
mean age of 57.2 yrs was found to be 272.3 ± 
43.4mg/dl and 210.54 ±31.5mg/dl respectively, and 
MTSC levels in fifty control cases, with a mean age 
group of 58.4 years, were found to be 183.4 ± 
34.4mg/dl (Table 1). 
Patients with tumor size less than 5 centimeters 
(cms) showed preoperative mean serum cholesterol 
levels of 261.6 ± 36.5mg/dl and a postoperative value 
of 201.9 ± 16.9mg/dl, those with tumor size between 
5.1 - 10cms showed preoperative mean serum 
cholesterol level of 265.8 ± 41.1mg/dl and 206.4 ± 
27.3mg/dl postoperatively while those with tumor size 
more than 10cms showed mean serum cholesterol level 
of 282.4 ± 64.8mg/dl preoperatively and 211.8 ± 
53.2mg/dl postoperatively (Table 2). 
Thirty patients with scirrhous type of carcinoma 
had a preoperative mean serum cholesterol level as 
237.4mg/dl, and twelve patients with a colloid type of 
carcinoma showed a preoperative level of 294.9 ± 
18.4mg/dl whereas eight patients with medullary type 
of carcinoma showed the highest preoperative level of 
324.3 ± 19.8mg/dl, whereas the corresponding 
postoperative values were 202.9 ± 30.0mg, 216.8 ± 
27.8 mg and 229.4 ± 29.8mg respectively (Table 3). 
 
Table 1. Mean Total Serum Cholesterol levels in control and test groups. 
 
Groups No. of cases Pre-op Serum Cholesterol (mg/dl) Post-op Serum Cholesterol (mg/dl) Range Mean + S.D. Range Mean + S.D. 
Control 50 138.8 - 286.0 188.4 ± 34.4 - - 
Test 50 173.0 - 349.5 272.4±24.4 148.0 - 280.6 210.5 ± 31.3 
 
Table 2. Mean Total Serum Cholesterol levels according to tumor size. 
 
Size of Tumor No. of cases Pre-op Serum Cholesterol (mg/dl) Post-op Serum Cholesterol (mg/dl) Range Mean + S.D. Range Mean + S.D. 
≤ 5cms 22 173 - 338 261.4 ± 54.8 148.0 - 280.6 214.8 ± 54.2 
5.1-10cms 18 206.3 - 334.0 265.8 ± 41.1 156.0 - 253.0 206.4 ± 27.3 
> 10cms 10 208.0 - 349.5 282.7 ± 36.5 148.0 - 280.6 211.9 ± 16.9 
 
Table 3. Mean Total Serum Cholesterol levels according to histological type. 
 
Histological type No. of cases Pre-op Serum Cholesterol (mg/dl) Post-op Serum Cholesterol (mg/dl) Range Mean + S.D. Range Mean ± S.D. 
Colloid 12 280.0 - 334.0 280.0 - 334.0 167.5 - 253.0 216.8 ±27.8 
Medullary 08 298.0 - 349.5 298.0 - 349.5 206.0 - 280.6 229.1±29.8 
Scirrhous 30 173.0 - 304.3 250.4 - 97.4 148.0 - 270.0 202. 9±30.1 
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The preoperative and postoperative mean serum 
cholesterol levels in twenty-eight patients with lymph 
node involvement came out to be 303.2 ± 26.1mg/dl 
and 223.5 ± 28.2mg/dl respectively, while in patients 
without any lymph node involvement, these values 
were 248.1 ± 36.8mg/dl and 200.3 ± 29.4mg/dl 
respectively. 
 
3. Discussion 
 
The main finding of the present study was the 
exceptionally raised pre-treatment serum total 
cholesterol level in patients of carcinoma breast, 
consistent with the findings of Chao et al.,2 and 
Alexopoulos et al.,3, 5 rather than the usual inverse 
relation of cholesterol and cancer. Although, several 
workers like Knekt et al.,6, Smith et al.,7 and 
Alexopoulos5 have agreed for the inverse relationship 
between cholesterol level and cancer incidence and 
mortality but Chao et al.,2, pointed to early mortality 
from various site-specific body cancer except for 
carcinoma breast, ovary and Hodgkins disease, when 
serum cholesterol decreased to half the initial levels. 
Alexopoulos et al.,3,5 demonstrated that cancer patients 
as a group revealed significantly lower total serum 
cholesterol values compared with the controls except 
for the breast cancer patients who revealed raised total 
serum cholesterol. 
In this study, 32 out of 50 patients were non-
vegetarian, which explains the hypothesis that increased 
dietary fat intake is positively associated with risk of 
breast cancer.8,9 The mean age of cases in the control 
and test groups were 58.5 and 57.7 years respectively, 
almost similar to the studies of Alexopoulos3,5. The 
mean total serum cholesterol (MTSC) level in control 
cases was found to be 188.4 ± 34.4mg/dl, compared 
with the finding of Alexopoulos et al.,3. The pre-
treatment MTSC levels of all breast cancer cases was 
272.3 ± 43.3mg/dl; very similar to the findings of 
Knekt et al.,6, but higher than the findings of 
Alexopoulos et al.,3,5, who have reported that untreated 
breast cancer is associated with hypercholesterolemia in 
contrast to most other tumors. The post-treatment 
MTSC levels were found to be 210.5 ± 31.5mg/dl, a 
value very similar to the findings of Alexopoulos et 
al.,5. In our study, the moderate difference between pre-
treatment and post-treatment values of MTSC (p<0.05) 
could be due to surgical trauma, blood loss and 
decreased desire of intake. 
Alexopoulos et al.,5 have reported that pre-
treatment hypercholesterolemia can be reversed by 
effective treatment, and breast cancer patients 
demonstrated an inverse pattern of change after 
completion of chemotherapy as compared to other 
groups of patients, their total serum cholesterol levels 
decreased instead of increasing, after therapy. 
Patients with breast tumor of a size less than 5cm, 
between 5.1 - 10cm and more than 10cm, exhibited a 
pre-treatment MTSC level of 261.3 ± 54.8mg/dl,    
265.8 ± 41.2mg/dl and 282.7 ± 4mg/dl respectively, and 
a post-treatment MTSC level of 206.1 ± 16.9mg/dl, 
211.5 ± 27.3mg/dl and 214.8 ± 53.2mg/dl respectively. 
The pre-treatment and post-treatment differences in 
serum cholesterol levels in various sizes of tumors were 
insignificant, although there was a gradual surge in 
serum cholesterol levels with increasing size. 
The histology of the carcinoma affected the serum 
cholesterol values as reported by Schatzkin et al.,10, 
who suggested that the inverse relation between 
cholesterol and cancer was more prominent for cancers 
of squamous epithelial than glandular epithelium. Thus, 
it would be of interest to examine the relation of 
cholesterol and cancer by histology prototypes. 
Keeping this aspect into account the present study 
showed varying levels of serum cholesterol levels with 
histological subtypes of breast cancers; with lowest 
level in cirrhotic and highest level in medullary 
carcinomas. The preoperative cholesterol levels 
gradually showed an increasing trend with significant 
variation (p<0.001) in three histological types of 
scirrhous, colloid to medullary carcinoma but 
postoperative readings were comparatively 
insignificant. 
The lymph node metastasis had an effect on serum 
cholesterol levels with the pre-treatment MTSC values 
of patients with Lymph node involvement, which was 
significantly higher than those without lymph node 
involvement was 248.1 ± 38.6mg/dl. The post-
treatment values for both came out to be insignificant in 
the present study. 
The present study helps us to conclude that dietary 
habits affect the association of cholesterol in breast 
cancer and size, histology and metastasis of the tumor 
effect such relationship. 
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